PHARMA SIGNALOPEN RESEARCH PLATFORM →
COMPANY RESEARCH PROFILE · UPDATED 2026-09-29

Alnylam

Commercial-stage biopharmaceutical company that develops RNA-interference therapeutics for rare, cardiometabolic, hepatic, and central nervous system diseases.

TICKERALNY
HEADQUARTERSMassachusetts, USA
STAGENot specified
ACTIVE TRIALS26

Therapeutic areas

Not specified

Selected products and programs

AmvuttraGivlaariOxlumoOnpattro

Linked curated drug profiles

No curated drug entity is linked in the current pilot.

Selected active clinical trials

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

Phase 3 · Recruiting · Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Phase 3 · Recruiting · Transthyretin Amyloidosis With Cardiomyopathy

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Phase 3 · Recruiting · High Risk Cardiovascular Disease

A Study to Evaluate ALN-4285 in Adult Healthy Volunteers

Phase 1 · Recruiting · Healthy Volunteers

A Study to Evaluate ALN-2232 in Participants With Obesity

Phase 1 · Recruiting · Obesity

A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus

Phase 2 · Recruiting · Type 2 Diabetes Mellitus (T2DM)

Selected patent records

US 8642076

patisiran sodium · Expires 2027-10-03

US 10131907

givosiran sodium · Expires 2028-08-24

US 8828956

givosiran sodium · Expires 2028-12-04

US 10806791

vutrisiran sodium · Expires 2028-12-04

US 9370581

vutrisiran sodium · Expires 2028-12-04

US 11141378

patisiran sodium · Expires 2029-04-15

Primary and company sources

Company and pipeline information can change. Verify material decisions against the linked primary sources.

Evidence & limits

Source: Open the source record

Record identifier
/companies/alnylam/
Event / action date
Not separately retained
Source update date
Not separately retained
Platform retrieval / processing date
Not separately retained

What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.

Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.

Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.

What this record means · Report an issue with this record